Slide 1: 2026 Interim Results
Elementis plc 2026 Interim Results 30 July 2026 Unique chemistry, sustainable solutions Unique chemistry, sustainable solutions
Slide 2: Cautionary statement
Cautionary statement This presentation, the presentation materials and discussion The Company is the holding company for a number of operationally may contain certain forecasts, projections and forward-looking distinct and autonomous subsidiaries that conduct the day-to-day statements—that is, state
Slide 3: Agenda
Agenda 01 Introduction and highlights Luc van Ravenstein 02 Financial performance Kath Kearney-Croft 03 Elevate Elementis Luc van Ravenstein 04 Lucchemistry, Unique Q&A sustainable van Ravenstein and Kath Kearney-Croft solutions 3
Slide 4: Strong H1 performance
Strong H1 performance Sharpened focus as a 'pure-play' in specialty chemicals Portfolio strengthened ‘Elevate Elementis’ on Revenue and profit and Confident of meeting track – strategic and growth; margin share buyback FY26 expectations financial progress improvement programme launched Unique chemis
Slide 5: New Elementis
New Elementis High-quality pure-play specialty chemicals business New Elementis: Alchemy acquired Pure-play specialties Pharmaceutical Chromium Talc manufacturing sold sold sold Personal Care Additives: small part of formulation, critical to performance Winning differentiators: Exited commoditised,
Slide 6: 'Elevate Elementis' strategy is on track
‘Elevate Elementis’ strategy is on track Strategic priorities and financial ambitions Three strategic priorities Medium-term ambitions H1 2026 delivery Accelerate sustainable growth Mid-single digit organic-led revenue 4.7% growth through the cycle Adjusted operating margin >23% 23.0% First choice f
Slide 7: Financial performance
Financial performance Kath Kearney-Croft, CFO Unique chemistry, sustainable solutions
Slide 8: Strong financial performance
Strong financial performance $m H1 25 H1 25 H1 26 % change3 (unless stated otherwise) (reported) (continuing) (continuing) (continuing) Revenue1 307.9 290.8 318.2 4.7% Adjusted operating profit1 65.3 62.9 73.2 9.8% Adjusted operating margin1 21.2% 21.6% 23.0% 140 bps Adjusted diluted EPS (cents) 1 6
Slide 9: Group revenue ($m)
Group revenue ($m) Strong performance in challenging market conditions 6.8 (8.7) 16.0 9.8 3.5 ( 318.2 (1.1) (7.6) 290.8 (4.3) (43) Coatings Personal 15.8 Care (3.3) (2.3) 0.2 Coatings Personal Care Unique chemistry, sustainable solutions H1 25 FX M&A Volume Price Mix H1 26 9
Slide 10: Group adjusted operating profit ($m)
Group adjusted operating profit ($m) Higher volume drop-through with margin growth supported by self-help actions 6.4 (0.5) 0.5 73.2 1.3 1.3 2.6 (0.8) Savings R&D 62.9 (3) 5 (6) Unique chemistry, sustainable solutions H1 25 FX M&A Volume Price/Mix1 Net Savings H1 26 21.6% 23.0% AOP2 margin Notes: 1.
Slide 11: Personal Care performance
Personal Care performance1 Strong revenue, profit and margin delivery Change $m H1 26 H1 25 (organic constant • Good growth in cosmetics, particularly strong in currency) Asia and skincare. Muted growth in North America due to isolated weaker demand in Q1 Revenue 109.2 99.3 2.9% • Profit and margin
Slide 12: Coatings performance
Coatings performance Continued margin progression $m H1 26 H1 25 Change (constant currency) • Higher revenue driven by strong growth in Asia, EMEA, LATAM and energy partially offset by weaker North America Revenue 209.0 191.5 5.6% • Margin performance reflects benefit of higher volumes, improved ass
Slide 13: Disciplined cash generation while investing for growth
Disciplined cash generation while investing for growth $m H1 26 H1 251 • Working capital outflow driven mainly by Adjusted EBITDA 84.1 73.8 higher receivables from increased sales and no factoring in H1 2026 Change in working capital (44.4) (27.4) • Capex higher due primarily to growth Capital expen
Slide 14: Robust balance sheet gives capital allocation optionality
Robust balance sheet gives capital allocation optionality Net debt to EBITDA ratio improved 185.4 17.2 0.5 (13.3) 6.7 163.8 (32.7) (3) Unique chemistry, sustainable solutions Net debt end 2025 Free cash flow Pharma disposal & discontinued operations Net share repurchases Dividends FX Net debt H1 202
Slide 15: Capital allocation
Capital allocation Balanced approach that prioritises growth, with progressive dividend and scope for additional returns. Investing Progressive Additional for growth dividend returns • Capex - focus on growth and • Maintain full year policy full ~30% • Look to maintain leverage over time productivit
Slide 16: Elevate Elementis
Elevate Elementis Luc van Ravenstein, CEO Unique chemistry, sustainable solutions
Slide 17: Generate value with our winning differentiators
Generate value with our winning differentiators Category Hectorite Rheology Formulation Solutions Our premium asset Our leading capability How we work with customers • Natural white clay, highly efficient • The science of flow—what makes • Our expertise to optimise formulations What is it? ingredien
Slide 18: Hectorite: a unique source of value creation
Hectorite: a unique source of value creation Consumer Double-digit revenue growth through the cycle Customer Formulation Processing Pure hectorite One of the largest commercial Hectorite modification and Inclusion of functional ingredients Versatile across Personal • Easy application high-grade mine
Slide 19: H1 progress against Elevate Elementis
H1 progress against Elevate Elementis Driving our three priorities Accelerate First choice Simpler, leaner sustainable growth for customers Elementis Significant improvement in OTIF Hectorite, skincare and suncare On track for $10m cost saving performance & St. Louis H1 spotlight launches target & l
Slide 20: Accelerate sustainable growth
Accelerate sustainable growth Significant addressable market and accelerating Hectorite launches in skin and suncare Perfect fit with room to grow Strong start to 2026 Acceleration in market adoption • Sustainability Elementis sales growth in skincare Hectorite accelerating in H1 2026 • Premium Text
Slide 21: First choice for customers
First choice for customers OTIF and St. Louis progress Significant progress OTIF Target: +20% improvement • OTIF performance has risen from 83% at end 2025 to 88% as at the end of June 2026 • Since end 2024, OTIF performance has increased by 1200 bps St. Louis Target: +30% capacity utilisation • c.2
Slide 22: Simpler, leaner Elementis
Simpler, leaner Elementis Simplification, agility and speed of execution • Realised $0.5m net cost savings, contributing to the net $4m targeted for the year Simpler and • Streamlined several functions Leaner • Executive Committee and senior leadership team rightsized Investment in • Investment in i
Slide 23: Summary and outlook
Summary and outlook 'New Elementis' coming through in our performance Sharpened focus Confident of Product Innovation Strong H1 On track for as a 'pure-play' in meeting FY26 Day, performance Elevate Elementis specialty chemicals expectations 3 November 2026 Unique chemistry, sustainable solutions 23
Slide 24: Q&A
Q&A Luc van Ravenstein, CEO Kath Kearney-Croft, CFO Unique chemistry, sustainable solutions
Slide 25: Appendix
Appendix Unique chemistry, sustainable solutions
Slide 26: Our global footprint and local-for-local model
Our global footprint and local-for-local model gives us operational resilience and agility Manufacturing R&D centre Hectorite mine Hectorite mine, California 11 Manufacturing sites 7 R&D centres Unique 4 chemistry, sustainable solutions Continents 26
Slide 27: Significant value creation potential
Significant value Elevate Elementis creation potential: Three strategic priorities: Revenue Growth1 MSD 2 Accelerate sustainable growth through the cycle Adjusted operation margin1: First choice for customers 23%+ Simpler, leaner Elementis Cash conversion1 >90% Unique chemistry, sustainable solution
Slide 28: Three strategic priorities
Three strategic priorities Accelerate First choice Simpler, leaner sustainable growth for customers Elementis Objectives +20% OTIF improvement Mid-single digit Increased efficiency and agility 30% capacity utilisation revenue growth Cost savings improvement at St. Louis Focus on winning differentiat
Slide 29: Personal Care innovation pipeline
Personal Care Innovation pipeline well positioned to capture new and emerging trends Trends Innovation • Launched BENTONE® ULTIMATE series used in makeup (lipstick) • Growing demand for natural • Breakthrough, patent-pending hectorite technology Colour products and skinification • >90% natural cosme
Slide 30: Coatings innovation pipeline
Coatings Innovation pipeline well positioned to capture new and emerging trends Trends Innovation • Launched Elementis Opacity Toolbox: enabling our customers to achieve superior coverage with less paint • Increased demand for • Powdered and biobased premium rheology (NiSATs1): +45% sustainable ingr
Slide 31: Building scale in large and attractive end markets
Building scale in large and attractive end markets Total addressable market Focus on selected high-value niches • Skin care – hectorite replacing synthetics & imparting premium textures >$1.5bn • Colour cosmetics – pre-formulated hectorite gels Existing Personal • Antiperspirants – high-efficacy act
Slide 32: Alchemy update
Alchemy update Delivering growth through complementary M&A Right in our sweet spot: • Experts in luxurious textures for skin care and cosmetics • Premium, natural rheology ingredients • Proven track record of revenue and profit growth Complementary and synergistic: • On track for double-digit growth
Slide 33: H1 sustainability highlights
H1 sustainability highlights 8 33 Safety Environment People Elementis Total Recordable Recordable Injuries Injury Rate (TRIR) Injuries / lost time accidents Lost-Time Accidents • Operational energy efficiency gains • Additional organisational structure TRIR balancing underlying emissions increase si
Slide 34: Net debt IFRS reconciliation
Net debt IFRS 16 reconciliation H1 26 Pre-IFRS 16 Basis Post-IFRS 16 Basis Bank loans and overdraft (250.0) (250.0) Lease liabilities – (17.4) Cash and cash equivalents 86.2 86.2 Net debt (163.8) (181.2) Adjusted operating profit1 132.7 132.7 Add: Depreciation and amortisation1 30.3 30.3 Less: Amort
Slide 35: Adjusting items
Adjusting items $m H1 2026 H1 2025 Business transformation 3.4 2.3 Acquisitions and disposals 0.6 – St. Louis operational transformation – 1.2 Cloud and data transformation 2.9 0.3 Sale of Middletown plant (1.4) 0.4 US tariff refund (1.2) – Environmental provisions – (0.4) St. Louis fire – 0.4 Amort
Slide 36: Pharmaceutical manufacturing sale transaction details
Pharmaceutical manufacturing sale transaction details Margin enhancing non-core disposal €m $m1 Enterprise value 34.3 39.8 Pension deficit (3.2) (3.7) Net cash and working capital 0.4 0.5 Transaction costs (0.7) (0.8) Unique chemistry, sustainable Net cash proceeds after transaction costs 30.8 solut
Slide 37: For more details please contact
Unique chemistry, sustainable solutions For more details United Kingdom Europe North America Asia please contact: Elementis plc Elementis Portugal, Elementis Duechem (Shanghai) The Bindery 5th Floor Unipessoal LDA 469 Old Trenton Road Chemical Co, LTD. elementis.com 51-53 Hatton Garden Rua de Santos